Respiratory sequelae of COVID-19: pulmonary and extrapulmonary origins, and approaches to clinical care and rehabilitation
Although the exact prevalence of post-COVID-19 condition (also known as long COVID) is
unknown, more than a third of patients with COVID-19 develop symptoms that persist for …
unknown, more than a third of patients with COVID-19 develop symptoms that persist for …
Cellular interplay in skeletal muscle regeneration and wasting: insights from animal models
Skeletal muscle wasting, whether related to physiological ageing, muscle disuse or to an
underlying chronic disease, is a key determinant to quality of life and mortality. However …
underlying chronic disease, is a key determinant to quality of life and mortality. However …
Balancing the value and risk of exercise-based therapy post-COVID-19: a narrative review
Coronavirus disease 2019 (COVID-19) can lead to ongoing symptoms such as
breathlessness, fatigue and muscle pain, which can have a substantial impact on an …
breathlessness, fatigue and muscle pain, which can have a substantial impact on an …
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Clinical trials evaluating the management of acute exacerbations of COPD assess
heterogeneous outcomes, often omitting those that are clinically relevant or more important …
heterogeneous outcomes, often omitting those that are clinically relevant or more important …
British thoracic society clinical statement on pulmonary rehabilitation
The evidence-based British Thoracic Society (BTS) Guideline for pulmonary rehabilitation
(PR) in adults was published in 2013. 1 There is a strong evidence base for the benefits of …
(PR) in adults was published in 2013. 1 There is a strong evidence base for the benefits of …
[HTML][HTML] Usability of wearable multiparameter technology to continuously monitor free-living vital signs in people living with chronic obstructive pulmonary disease …
G Hawthorne, N Greening, D Esliger… - JMIR Human …, 2022 - humanfactors.jmir.org
Background: Vital signs monitoring (VSM) is routine for inpatients, but monitoring during free-
living conditions is largely untested in chronic obstructive pulmonary disease (COPD) …
living conditions is largely untested in chronic obstructive pulmonary disease (COPD) …
Bidirectional transitions of sarcopenia states in older adults: The longitudinal evidence from CHARLS
YX Luo, XH Zhou, T Heng, LL Yang… - Journal of Cachexia …, 2024 - Wiley Online Library
Background Sarcopenia, the age‐related loss of muscle mass and function, brings multiple
adverse outcomes including disability and death. Several sarcopenia consensuses have …
adverse outcomes including disability and death. Several sarcopenia consensuses have …
[HTML][HTML] Acute Sarcopenia: Mechanisms and Management
Background: Acute sarcopenia refers to the swift decline in muscle function and mass
following acute events such as illness, surgery, trauma, or burns that presents significant …
following acute events such as illness, surgery, trauma, or burns that presents significant …
[HTML][HTML] Resistance Training in Post-COVID Recovery: Rationale and Current Evidence
During hospitalisation with COVID-19, individuals may experience prolonged periods of
immobilisation. Combined with the inflammatory effects of the virus, this may lead to a …
immobilisation. Combined with the inflammatory effects of the virus, this may lead to a …
Assessing treatment success or failure as an outcome in randomised clinical trials of COPD exacerbations. A meta-epidemiological study
AG Mathioudakis, S Ananth, T Bradbury, B Csoma… - Biomedicines, 2021 - mdpi.com
A recently published ERS core outcome set recommends that all trials of COPD
exacerbation management should assess the treatment success (or “cure” of the …
exacerbation management should assess the treatment success (or “cure” of the …